ICRIER and RxGPS co-hosted a day-long, intensive stakeholder meeting, to begin an ongoing dialogue around serialization and traceability in India and around the world, allowing stakeholders to discuss the Serialization and traceability issues and explore solutions, as well as to review systems being tested in other markets. This meeting aimed to increase coordination of stakeholders … Continue reading Stakeholder Consultation on Drug Serialization and Traceability in India – 3rd March 2017

In the second year of its research program on Drug Regulatory Reforms in India, ICRIER’s Health Policy Initiative organized a Brainstorming Session on 1 March, 2016. The main purpose of this Session was to elicit views of a select group of eminent experts and stakeholders to guide our research papers in the year 2016 – … Continue reading Brainstorming Session on Drug Regulatory Reforms in India-1st March 2016

As a part of ICRIER’s Health Policy Initiative, an inaugural roundtable discussion was conducted on importance of strong drug regulatory systems in India on November 3, 2015 in New Delhi. It was attended by distinguished experts from the academia,industry representatives, patient groups and policymakers. The discussions deliberated on the following two themes- 1) Clinical trials … Continue reading Special Round Table on Importance of Strong Drug Regulatory Systems –3rd Nov, 2015